IQVIA · 4 days ago
Clinical Research Associate, Sponsor Dedicated, Oncology
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. As a Clinical Research Associate, you will ensure study sites operate smoothly and efficiently, conducting site visits and managing recruitment plans while maintaining compliance with regulatory guidelines.
AnalyticsHealth CareLife Science
Responsibilities
Conduct selection, initiation, monitoring, and close-out visits, ensuring compliance with Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines
Collaborate with sites to develop and track recruitment plans, ensuring project needs are met
Provide protocol training and maintain regular communication with sites to manage expectations and address issues
Evaluate site practices for protocol adherence and escalate quality issues as needed
Track regulatory submissions, recruitment, enrollment, and data management to ensure smooth study progress
Maintain essential documents in the Trial Master File (TMF) and Investigator’s Site File (ISF) as per regulatory requirements
Mentor clinical staff through co-monitoring and training visits
Work closely with study team members to support project execution
Manage site finances and retrieve invoices as per local requirements
Qualification
Required
BS Degree in a scientific discipline or healthcare preferred
Minimum 1 year of on-site monitoring experience in oncology; 2 years preferred
Strong understanding of GCP and ICH guidelines, with expertise in oncology protocols
Proficiency in Microsoft Office, excellent communication skills, and strong organizational and problem-solving abilities
Effective time and financial management, and the ability to build strong working relationships
Benefits
Incentive plans
Bonuses
Health and welfare and/or other benefits
Company
IQVIA
IQVIA provides analytics, compliance, and management solutions to the life sciences industry.
Funding
Current Stage
Public CompanyTotal Funding
$3.5B2025-06-02Post Ipo Debt· $2B
2023-11-14Post Ipo Debt· $500M
2023-05-18Post Ipo Debt· $1B
Leadership Team
Recent News
Company data provided by crunchbase